These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28784672)

  • 1. Pharmacokinetics of the Protein Microbicide 5P12-RANTES in Sheep following Single-Dose Vaginal Gel Administration.
    McBride JW; Dias N; Cameron D; Offord RE; Hartley O; Boyd P; Kett VL; Malcolm RK
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES.
    McBride JW; Boyd P; Dias N; Cameron D; Offord RE; Hartley O; Kett VL; Malcolm RK
    J Control Release; 2019 Mar; 298():1-11. PubMed ID: 30731150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES.
    McBride JW; Malcolm RK; Dias N; Cameron D; Offord RE; Hartley O; Kett VL; Devlin B; Boyd P
    Int J Pharm; 2019 Jun; 564():207-213. PubMed ID: 30999049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.
    Kish-Catalone TM; Lu W; Gallo RC; DeVico AL
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1497-509. PubMed ID: 16569870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage.
    Cerini F; Offord R; McGowan I; Hartley O
    AIDS Res Hum Retroviruses; 2017 Aug; 33(8):768-777. PubMed ID: 28177261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a CCR5 inhibitor in rhesus macaques following vaginal, rectal and oral application.
    Malcolm RK; Lowry D; Boyd P; Geer L; Veazey RS; Goldman L; Klasse PJ; Shattock RJ; Moore JP
    J Antimicrob Chemother; 2014 May; 69(5):1325-9. PubMed ID: 24381072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.
    Kish-Catalone T; Pal R; Parrish J; Rose N; Hocker L; Hudacik L; Reitz M; Gallo R; Devico A
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):33-42. PubMed ID: 17263630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides.
    Holt JD; Cameron D; Dias N; Holding J; Muntendam A; Oostebring F; Dreier P; Rohan L; Nuttall J
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3761-70. PubMed ID: 25845860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris.
    Cerini F; Gaertner H; Madden K; Tolstorukov I; Brown S; Laukens B; Callewaert N; Harner JC; Oommen AM; Harms JT; Sump AR; Sealock RC; Peterson DJ; Johnson SK; Abramson SB; Meagher M; Offord R; Hartley O
    Protein Expr Purif; 2016 Mar; 119():1-10. PubMed ID: 26506568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use.
    Nedellec R; Coetzer M; Lederman MM; Offord RE; Hartley O; Mosier DE
    PLoS One; 2011; 6(7):e22020. PubMed ID: 21760945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc.
    Forbes CJ; Lowry D; Geer L; Veazey RS; Shattock RJ; Klasse PJ; Mitchnick M; Goldman L; Doyle LA; Muldoon BC; Woolfson AD; Moore JP; Malcolm RK
    J Control Release; 2011 Dec; 156(2):161-9. PubMed ID: 21864598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.
    Malcolm RK; Veazey RS; Geer L; Lowry D; Fetherston SM; Murphy DJ; Boyd P; Major I; Shattock RJ; Klasse PJ; Doyle LA; Rasmussen KK; Goldman L; Ketas TJ; Moore JP
    Antimicrob Agents Chemother; 2012 May; 56(5):2251-8. PubMed ID: 22330914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides.
    Forbes CJ; McCoy CF; Murphy DJ; Woolfson AD; Moore JP; Evans A; Shattock RJ; Malcolm RK
    J Pharm Sci; 2014 May; 103(5):1422-32. PubMed ID: 24585370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Dapivirine Vaginal Gel and Film Formulation Pharmacokinetics and Pharmacodynamics (FAME 02B).
    Robinson JA; Marzinke MA; Bakshi RP; Fuchs EJ; Radebaugh CL; Aung W; Spiegel HM; Coleman JS; Rohan LC; Hendrix CW
    AIDS Res Hum Retroviruses; 2017 Apr; 33(4):339-346. PubMed ID: 27809557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits.
    Clark MR; Friend DR
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1458-66. PubMed ID: 22394281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES.
    Wiktor M; Hartley O; Grzesiek S
    Biophys J; 2013 Dec; 105(11):2586-97. PubMed ID: 24314089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film.
    Bunge KE; Dezzutti CS; Rohan LC; Hendrix CW; Marzinke MA; Richardson-Harman N; Moncla BJ; Devlin B; Meyn LA; Spiegel HM; Hillier SL
    J Acquir Immune Defic Syndr; 2016 Apr; 71(5):498-505. PubMed ID: 26565716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.
    Pereira LE; Singletary T; Martin A; Dinh CT; Deyounks F; Holder A; McNicholl J; Buckheit KW; Buckheit RW; Ham A; Katz DF; Smith JM
    Drug Deliv Transl Res; 2018 Oct; 8(5):1180-1190. PubMed ID: 29761350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and efficacy of a vaginally administered maraviroc gel in rhesus macaques.
    Malcolm RK; Forbes CJ; Geer L; Veazey RS; Goldman L; Klasse PJ; Moore JP
    J Antimicrob Chemother; 2013 Mar; 68(3):678-83. PubMed ID: 23111849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.